After a year of hesitation in the face of pending cost control guidelines, Vertex Pharmaceuticals has submitted Trikafta to Health Canada for approval – now the hard work begins, writes Jeremie Saunders.
Cystic fibrosis drug Trikafta could change lives – if Health Canada approves it
